BV-CAP protocol
chemotherapy protocol consisting of bleomycin, vincristine, cytoxan, adriamyucin & cis-platinum
Also Known As:
BV CAP; CAVBP
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Therapy Context: Research Results
Related Diseases
| 1. | Disease Progression
|
| 2. | Neoplasms (Cancer)
|
| 3. | Non-Hodgkin Lymphoma (Lymphosarcoma)
11/01/1990
- " CAVBP/DEP alternating chemotherapy for the treatment of intermediate and high grade non Hodgkin's lymphoma: final results of a pilot study." 11/01/1990
- " Between May 1984 and September 1986, 40 patients with intermediate or high grade non Hodgkin's lymphoma were treated with a novel protocol, which alternated a conventional regimen consisting of cyclophosphamide, doxorubicin, vincristine, bleomycin, and prednisone (CAVBP) with a second chemotherapy regimen, including two drugs with newly discovered activity against lymphomas, such as cis-platin, etoposide, and prednisone (DEP). "
|
| 4. | Lymphoma (Lymphomas)
11/01/1990
- " Between May 1984 and September 1986, 40 patients with intermediate or high grade non Hodgkin's lymphoma were treated with a novel protocol, which alternated a conventional regimen consisting of cyclophosphamide, doxorubicin, vincristine, bleomycin, and prednisone (CAVBP) with a second chemotherapy regimen, including two drugs with newly discovered activity against lymphomas, such as cis-platin, etoposide, and prednisone (DEP). "
|
| 5. | Androblastoma of ovary
|
|
Related Drugs and Biologics
Related Therapies and Procedures